We are live on ! Find out more
FMW

Farr Miller & Washington Portfolio holdings

AUM $1.53B
1-Year Est. Return 32.74%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+32.74%
3 Year Est. Return
+62.27%
5 Year Est. Return
+125.67%
10 Year Est. Return
AUM
$1.05B
AUM Growth
+$25.6M
Cap. Flow
-$12.2M
Cap. Flow %
-1.17%
Top 10 Hldgs %
35.17%
Holding
159
New
5
Increased
59
Reduced
47
Closed
1

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19M
2
GE icon
GE Aerospace
GE
+$1.56M
3
RTX icon
RTX Corp
RTX
+$491K
4
GMED icon
Globus Medical
GMED
+$431K
5
SLB icon
SLB Ltd
SLB
+$424K

Top Sells

Rank Stock Value
1
COL
Rockwell Collins
COL
+$25.7M
2
SFM icon
Sprouts Farmers Market
SFM
+$8.37M
3
SYK icon
Stryker
SYK
+$454K
4
PG icon
Procter & Gamble
PG
+$348K
5
INTU icon
Intuit
INTU
+$320K

Sector Composition

Rank Sector Weight
1 Healthcare 23.44%
2 Technology 15.1%
3 Financials 12.61%
4 Industrials 12.04%
5 Consumer Staples 11.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$599B
$41.1M 3.92%
316,258
-1,028
-0.3% -$136K
MSFT icon
2
Microsoft
MSFT
$2.99T
$39.3M 3.75%
528,114
-4,229
-0.8% -$309K
ABT icon
3
Abbott
ABT
$177B
$38.8M 3.7%
726,313
-1,009
-0.1% -$50.6K
PG icon
4
Procter & Gamble
PG
$347B
$38.3M 3.65%
420,920
-3,819
-0.9% -$348K
ACN icon
5
Accenture
ACN
$88.6B
$37.2M 3.54%
275,143
-1,711
-0.6% -$223K
GS icon
6
Goldman Sachs
GS
$311B
$36.7M 3.5%
154,867
+255
+0.2% +$57.5K
FDX icon
7
FedEx
FDX
$73.1B
$35.7M 3.41%
158,401
-593
-0.4% -$126K
CVS icon
8
CVS Health
CVS
$137B
$35.6M 3.39%
437,664
+4,640
+1% +$367K
PNC icon
9
PNC Financial Services
PNC
$99.8B
$34.2M 3.26%
253,784
-393
-0.2% -$50.4K
SYK icon
10
Stryker
SYK
$122B
$31.7M 3.03%
223,468
-3,165
-1% -$454K
LOW icon
11
Lowe's Companies
LOW
$115B
$31.5M 3%
393,627
-972
-0.2% -$74.4K
CTSH icon
12
Cognizant
CTSH
$21.1B
$29.1M 2.77%
400,974
+754
+0.2% +$53K
JPM icon
13
JPMorgan Chase
JPM
$901B
$29M 2.76%
303,368
+3,816
+1% +$352K
PEP icon
14
PepsiCo
PEP
$185B
$28.6M 2.73%
256,724
+2,230
+0.9% +$258K
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$4.3T
$28.5M 2.72%
584,840
+3,400
+0.6% +$161K
INTU icon
16
Intuit
INTU
$80.4B
$26.8M 2.55%
188,337
-2,319
-1% -$320K
CVX icon
17
Chevron
CVX
$378B
$26.5M 2.53%
225,681
+885
+0.4% +$96.6K
DCI icon
18
Donaldson
DCI
$10.4B
$25.5M 2.43%
554,511
+2,420
+0.4% +$112K
CL icon
19
Colgate-Palmolive
CL
$73.6B
$25.3M 2.42%
347,752
-2,110
-0.6% -$152K
RTX icon
20
RTX Corp
RTX
$262B
$25.3M 2.41%
346,176
+6,634
+2% +$491K
BMY icon
21
Bristol-Myers Squibb
BMY
$123B
$24.3M 2.32%
381,639
+324,976
+574% +$19M
VMI icon
22
Valmont Industries
VMI
$10.2B
$24.1M 2.29%
152,161
+419
+0.3% +$63.1K
MDT icon
23
Medtronic
MDT
$107B
$23.2M 2.21%
298,264
-3,501
-1% -$291K
TFC icon
24
Truist Financial
TFC
$62.3B
$22.6M 2.16%
481,937
+1,812
+0.4% +$83.3K
DHR icon
25
Danaher
DHR
$142B
$22M 2.1%
289,780
+1,169
+0.4% +$86.5K

Similar funds

Farr Miller & Washington's Q3 2017 Portfolio in Review

As of Q3 2017, Farr Miller & Washington held 159 positions worth $1.05B, up 2.5% from $1.02B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 3.8%. Farr Miller & Washington opened 5 new positions and exited 1, leaving the 159-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

  • Farr Miller & Washington's largest Q3 2017 buy was Globus Medical: 14,110 shares worth $419K.
  • Farr Miller & Washington added most to Bristol-Myers Squibb in Q3 2017, an estimated $19M increase.
  • Farr Miller & Washington's biggest Q3 2017 reduction was Rockwell Collins, cutting an estimated $25.7M.
  • Farr Miller & Washington fully exited Vanguard Dividend Appreciation ETF in Q3 2017, selling an estimated $238K.
  • Farr Miller & Washington's ten largest holdings make up 35% of its $1.05B portfolio in Q3 2017.
  • Farr Miller & Washington opened 5 new positions and closed 1 in Q3 2017.
  • Farr Miller & Washington's portfolio value rose 2.5% quarter-over-quarter to $1.05B.

Based on Farr Miller & Washington's 13F filing for Q3 2017, filed 9 Nov 2017.